Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTwentyfour Sel Regulatory News (SMIF)

Share Price Information for Twentyfour Sel (SMIF)

Share Price is delayed by 15 minutes
Get Live Data
85.90    0.10 (0.12%)
Bid:
85.90
Ask:
86.50
Spread: 0.60 (0.698%)
Market Cap: £303.32m
SMIF Live PriceLast checked at - London Stock Exchange

Intraday Twentyfour Sel Share Chart

Investor Update Presentation July 2025

23 Jul 2025 09:00

TwentyFour Select Monthly Income Fund - Investor Update Presentation July 2025

TwentyFour Select Monthly Income Fund - Investor Update Presentation July 2025

PR Newswire

LONDON, United Kingdom, July 23

23 July 2025

 

TwentyFour Select Monthly Income Fund Limited

 

 

Investor Update Presentation

 

 

TwentyFour Select Monthly Income Fund Limited ("the Company" or "SMIF") has today published an Investor Update Presentation. Copies can be downloaded from the Company's website: Please click here to view the presentation 

For professional/institutional investors: https://www.twentyfouram.com/view/GG00BJVDZ946/twentyfour-select-monthly-income-fund

 

For further information, please contact:

Numis Securities Limited:

George Shiel

+44 (0)20 7260 1000

Hugh Jonathan

 

 

TwentyFour Select Monthly Income Fund Limited:

TwentyFour Sales

+44 (0)20 7015 8900

 

 

 

The Company's LEI is 549300P9Q5O2B3RDNF78

 

About SMIF:

 

SMIF is a London listed closed-ended investment company which is designed to take advantage of the premium returns available from "less liquid" instruments across the debt spectrum.

 

 


TwentyFour Select Monthly Income Fund - Investor update - Jul 2025 - FINAL

Date   Source Headline
5th Jun 20265:19 pmPRNIssue of Equity
4th Jun 20264:33 pmPRNNet Asset Value(s)
2nd Jun 20269:05 amPRNTender Submission Deadline Results
1st Jun 20264:16 pmPRNNet Asset Value(s)
1st Jun 202611:42 amPRNTotal Voting Rights
28th May 20265:10 pmPRNNet Asset Value(s)
22nd May 20265:46 pmPRNIssue of Equity
21st May 20262:45 pmPRNNet Asset Value(s)
19th May 202612:37 pmPRNResult of Extraordinary General Meeting
18th May 20267:00 amPRNNotice of Interim Results and Investor Presentation via Investor Meet Company
15th May 20267:00 amPRNMonthly Factsheet & Commentary - April 2026
14th May 20264:52 pmPRNNet Asset Value(s)
14th May 20261:48 pmPRNDividend Announcement
7th May 20263:39 pmPRNNet Asset Value(s)
5th May 20269:17 amPRNNet Asset Value(s)
1st May 202610:14 amPRNTotal Voting Rights
30th Apr 20265:43 pmPRNNet Asset Value(s)
28th Apr 20265:23 pmPRNNotice of EGM
23rd Apr 20264:28 pmPRNNet Asset Value(s)
20th Apr 20269:15 amPRNIssue of Equity
20th Apr 20269:00 amPRNIssue of Equity
17th Apr 202612:37 pmPRNNet Asset Value(s)
17th Apr 20267:00 amPRNMonthly Factsheet & Commentary - March 2026
16th Apr 20261:15 pmPRNDividend Declaration
9th Apr 20265:16 pmPRNNet Asset Value(s)
7th Apr 20263:28 pmPRNTender Results
2nd Apr 20265:34 pmPRNNet Asset Value(s)
1st Apr 20265:52 pmPRNNet Asset Value(s)
26th Mar 20263:35 pmPRNNet Asset Value(s)
19th Mar 20264:08 pmPRNNet Asset Value(s)
19th Mar 202611:58 amPRNDirector Dealing - Amendment
16th Mar 20261:59 pmRNSDirector Dealing
16th Mar 20261:59 pmPRNDirector Dealing
13th Mar 20263:56 pmRNSDirector Dealing
13th Mar 20263:56 pmPRNDirector Dealing
13th Mar 20262:27 pmRNSDirector Dealing
13th Mar 20262:27 pmPRNDirector Dealing
13th Mar 20267:00 amRNSMonthly Factsheet & Commentary - February 2026
13th Mar 20267:00 amPRNMonthly Factsheet & Commentary - February 2026
12th Mar 20264:52 pmPRNNet Asset Value(s)
12th Mar 20261:26 pmRNSDividend Declaration
5th Mar 20263:30 pmPRNNet Asset Value(s)
3rd Mar 20268:54 amPRNTender Submission Deadline Results
2nd Mar 20265:51 pmPRNNet Asset Value(s)
2nd Mar 202611:07 amPRNTotal Voting Rights
26th Feb 20264:26 pmPRNNet Asset Value(s)
20th Feb 20264:00 pmPRNIssue of Equity
19th Feb 20264:15 pmPRNNet Asset Value(s)
13th Feb 20265:45 pmPRNIssue of Equity
13th Feb 20267:00 amPRNMonthly Factsheet & Commentary - January 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.